A Postgraduate certificate that will bring you up to date with the challenges of the pharmaceutical industry in the development of innovative treatments”

In a context of access to innovation, it is necessary for healthcare professionals to correctly manage clinical and budgetary uncertainty. Thus, the current challenges revolve around the increase in life expectancy, financing and, in particular, the procedure and policy for setting drug prices. 

In this current scenario, it is essential for the specialist to be aware of the different Skateholders  and their interests, the challenges of the pharmaceutical industry, framed within the framework of business ethics and bioethics, and the trend towards sustainability in the sector through innovation. All these elements are indispensable and demanded by large multinational companies around the world that work in the development, research and commercialization of treatments. For this reason, TECH has decided to create this Postgraduate certificate in Access to the Medication Environment, where the main developments in the sector will be discussed in detail over a six-week period.

A program taught exclusively online, which from the outset explores the role of the pharmaceutical industry in the provision of health care systems, to gradually unravel the advances in the development of personalized medicines, the latest strategies used in the relationship with different types of customers, as well as the current methods of financing.  

This is all done through innovative multimedia didactic material (video summaries, videos in detail), essential readings and case studies to which the professionals will have access whenever they wish, from their computer, cell phone or Tablet with an internet connection. Additionally, the Relearning system, a methodology used by this academic institution, will allow reduce the long hours of study, so common in other teaching methods. 

The medical specialist is faced with a flexible university degree that can be taken comfortably at any time of the day, without attendance or fixed class schedules. An ideal academic option for those seeking to combine their professional responsibilities with a high quality Postgraduate certificate.  

A 100% online program focused on showing you the latest approach strategies used to obtain an efficient relationship with different clients”

This Postgraduate certificate in Access to the Medication Environment contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of case studies presented by experts in medicine and the pharmaceutical industry 
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where the self-assessment process can be carried out to improve learning
• Its special emphasis on innovative methodologies  
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection work
• Content that is accessible from any fixed or portable device with an Internet connection

You have a large library of multimedia resources that you can access at any time of the day from your computer with an internet connection”

The program’s teaching staff includes professionals from sector who contribute their work experience to this program, as well as renowned specialists from leading societies and prestigious universities.

Its multimedia content, developed with the latest educational technology, will allow the professional a situated and contextual learning, that is, a simulated environment that will provide an immersive education programmed to prepare in real situations.

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the academic year For this purpose, the student will be assisted by an innovative interactive video system created by renowned and experienced experts.

If you are looking for an academic option compatible with your responsibilities, this Postgraduate certificate offers you the flexibility you need"

An intensive and advanced syllabus that will keep you abreast of trends in the Access to Medication Environment"

The syllabus of this university program will lead the medical professional to be aware of the latest developments and advances in relation to the Access to Medication Environment. For this purpose, multimedia resources (video summaries, detailed videos), specialized readings and case studies are available for easy access from any electronic device with an Internet connection. Likewise, the Relearning system will favor the progress through the syllabus in a much more natural and agile way.

A study plan that will allow you to delve into the current challenges of the pharmaceutical industry in the provision of health care systems”

Module 1. The medication access environment in the 21st century

1.1. Role of the pharmaceutical industry in the provision of health care in health care systems

1.1.1. Core competencies that a public health administration should have
1.1.2. Constantly changing healthcare models Emergence of new technologies, need for greater efficiency and sustainability
1.1.3. Innovative industry challenges for the development of innovative treatments. The benefits of public-private collaboration in R&D
1.1.4. Challenges of the Pharmaceutical Industry in market access. The benefits Public-Private Partnership Models

1.2. Current challenges and pricing and reimbursement

1.2.1. Challenges for the NHS. Increased life expectancy-timeliness more sophisticated medications uncertainty management
1.2.2. Pricing and financing procedure. Ministries of health, price commissions, pharmaceutical benefit advisory committees, etc
1.2.3. Medication pricing and pricing policies
1.2.4. Current panorama of innovative drug financing. Uncertainty management
1.2.5. Models of access to innovation and management of clinical and budgetary uncertainty by the pharmaceutical industry

1.3. Stakeholders of the pharmaceutical industry I

1.3.1. The different  Stakeholders and their interests
1.3.2. Relationship between industry and health care managers: public and private spheres
1.3.3. Relationship between industry and public administrations
1.3.4. Relations with healthcare professionals

1.4. Stakeholders of the pharmaceutical industry II

1.4.1. Patient relations as a key stakeholder in the healthcare environment
1.4.2. Relations with other  Stakeholders: scientific societies, professional associations,Lobby and influence groups, political institutions, media

1.5. Types of Drugs Innovative medicines

1.5.1. Types of medications: innovators, generics and biosimilars
1.5.2. Market introduction of an innovative medication. Importance of good identification according to medication type
1.5.3. Approach and relationship strategy with the different customers
1.5.4. Rare diseases and orphan medications
1.5.5. Personalized Medicine

1.6. Types of Drugs Generic and biosimilar drugs

1.6.1. Differences between generics, biosimilars and originator drugs
1.6.2. Role of generics and biosimilars in the pharmaceutical market
1.6.3. Approach and relationship strategy with the different customers
1.6.4. Forms of contracting, tenders and central purchasing office
1.6.5. Substitution, interchangeability of generic drugs

1.7. Business ethics and Bioethics

1.7.1. Internal compliance policies of the pharmaceutical company
1.7.2. Transparency of the pharmaceutical industry's interrelationships

1.8. New challenges

1.8.1. New diseases with uncovered medical needs
1.8.2. High time and costs for the development of a new medication. Well-defined investment strategies
1.8.3. Need to implement new technologies in the research, development and production processes of the innovative medication
1.8.4. Competitor entry and shortening of the drug life cycle
1.8.5. Sustainability, equity and information management systems

1.9. Trends in the Pharmaceutical Industry

1.9.1. Personalized and Precision Medicine
1.9.2. Patients' role in decision making
1.9.3. The Transparency Commitment
1.9.4. Basis for public-private partnerships

1.10. From universal access to innovative medications to cost control

1.10.1. Evolution of access to innovative medicines
1.10.2. The Cost of Medication
1.10.3. Clinical Relevance
1.10.4. The decision-makers map
1.10.5. Searching for the right balance

An academic option that will show you the pharmaceutical trends around personalized and precision medicine"